Pharmacokinetics of the drugs and their biological response in ECMO patients
-
- STATUS
- Not Recruiting
-
- participants needed
- 50
Summary
Patients with severe pulmonary problems are occasionally placed on extracorporal membrane oxygenation ( ECMO) to provide a bridge during the time when lungs alone cannot provide necessary support. This procedure is gaining prominence but it is largely unknown how medications, especially antibiotics, given to the patient on ECMO is distributed throughout the body as compared to patients without ECMO. Since the serum level of medication determines biological activity of the drug, it is important to know if there is a difference in drug distribution between ECMO and non-ECMO patients. We already have well established data on several antibiotics on non-ECMO as a part of FDA labeling. Our study will help to determine if the concentration of currently prescribed are sufficient enough to reach their intended concentration in the study.
Description
FAQ
Details
| Condition | Hypoxia | Extracorporeal Membrane Oxygenation Complication |
|---|---|
| Age | 99years or below |
| Clinical Study Identifier | TBD |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.